nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—SLC22A6—Furosemide—dilated cardiomyopathy	0.49	1	CbGbCtD
Didanosine—SLC29A2—cardiac ventricle—dilated cardiomyopathy	0.0294	0.212	CbGeAlD
Didanosine—SLC29A2—myocardium—dilated cardiomyopathy	0.0276	0.199	CbGeAlD
Didanosine—PNP—Testosterone Propionate—Spironolactone—dilated cardiomyopathy	0.0195	1	CbGdCrCtD
Didanosine—SLC29A2—heart—dilated cardiomyopathy	0.0193	0.139	CbGeAlD
Didanosine—SLC29A2—cardiac atrium—dilated cardiomyopathy	0.0165	0.119	CbGeAlD
Didanosine—SLC29A1—cardiac ventricle—dilated cardiomyopathy	0.0146	0.105	CbGeAlD
Didanosine—SLC29A1—myocardium—dilated cardiomyopathy	0.0137	0.0987	CbGeAlD
Didanosine—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.0114	0.0364	CcSEcCtD
Didanosine—PNP—Purine catabolism—GPX1—dilated cardiomyopathy	0.0109	0.287	CbGpPWpGaD
Didanosine—SLC29A1—heart—dilated cardiomyopathy	0.00956	0.0689	CbGeAlD
Didanosine—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00852	0.0271	CcSEcCtD
Didanosine—Drug interaction—Furosemide—dilated cardiomyopathy	0.00852	0.0271	CcSEcCtD
Didanosine—SLC29A1—cardiac atrium—dilated cardiomyopathy	0.00818	0.0589	CbGeAlD
Didanosine—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00805	0.0256	CcSEcCtD
Didanosine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00758	0.0242	CcSEcCtD
Didanosine—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.0066	0.021	CcSEcCtD
Didanosine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00645	0.0205	CcSEcCtD
Didanosine—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00639	0.0204	CcSEcCtD
Didanosine—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00593	0.0189	CcSEcCtD
Didanosine—Malaise—Spironolactone—dilated cardiomyopathy	0.00573	0.0182	CcSEcCtD
Didanosine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00568	0.0181	CcSEcCtD
Didanosine—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00558	0.147	CbGpPWpGaD
Didanosine—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00557	0.0177	CcSEcCtD
Didanosine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00534	0.017	CcSEcCtD
Didanosine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00518	0.0165	CcSEcCtD
Didanosine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00507	0.0162	CcSEcCtD
Didanosine—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00495	0.0158	CcSEcCtD
Didanosine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00493	0.0157	CcSEcCtD
Didanosine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00486	0.0155	CcSEcCtD
Didanosine—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00479	0.0153	CcSEcCtD
Didanosine—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00466	0.0149	CcSEcCtD
Didanosine—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00452	0.0144	CcSEcCtD
Didanosine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00447	0.0142	CcSEcCtD
Didanosine—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00445	0.0142	CcSEcCtD
Didanosine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00441	0.0141	CcSEcCtD
Didanosine—PNP—Purine metabolism—GPX1—dilated cardiomyopathy	0.0042	0.11	CbGpPWpGaD
Didanosine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00418	0.0133	CcSEcCtD
Didanosine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00413	0.0131	CcSEcCtD
Didanosine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0041	0.0131	CcSEcCtD
Didanosine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00382	0.0122	CcSEcCtD
Didanosine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00367	0.0117	CcSEcCtD
Didanosine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00365	0.0116	CcSEcCtD
Didanosine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00355	0.0113	CcSEcCtD
Didanosine—Flatulence—Furosemide—dilated cardiomyopathy	0.0034	0.0108	CcSEcCtD
Didanosine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00336	0.0107	CcSEcCtD
Didanosine—Vomiting—Spironolactone—dilated cardiomyopathy	0.0033	0.0105	CcSEcCtD
Didanosine—Rash—Spironolactone—dilated cardiomyopathy	0.00327	0.0104	CcSEcCtD
Didanosine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00327	0.0104	CcSEcCtD
Didanosine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00325	0.0104	CcSEcCtD
Didanosine—Headache—Spironolactone—dilated cardiomyopathy	0.00325	0.0103	CcSEcCtD
Didanosine—Anaemia—Furosemide—dilated cardiomyopathy	0.00319	0.0102	CcSEcCtD
Didanosine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00314	0.00999	CcSEcCtD
Didanosine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.0031	0.00986	CcSEcCtD
Didanosine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00309	0.00985	CcSEcCtD
Didanosine—Nausea—Spironolactone—dilated cardiomyopathy	0.00308	0.00981	CcSEcCtD
Didanosine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00298	0.00949	CcSEcCtD
Didanosine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00288	0.00916	CcSEcCtD
Didanosine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00282	0.00898	CcSEcCtD
Didanosine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00276	0.00879	CcSEcCtD
Didanosine—Anorexia—Furosemide—dilated cardiomyopathy	0.00269	0.00856	CcSEcCtD
Didanosine—Chills—Lisinopril—dilated cardiomyopathy	0.00267	0.00851	CcSEcCtD
Didanosine—Alopecia—Lisinopril—dilated cardiomyopathy	0.00263	0.00838	CcSEcCtD
Didanosine—Flatulence—Lisinopril—dilated cardiomyopathy	0.00255	0.00814	CcSEcCtD
Didanosine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00253	0.00807	CcSEcCtD
Didanosine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00245	0.00781	CcSEcCtD
Didanosine—Pain—Furosemide—dilated cardiomyopathy	0.00241	0.00768	CcSEcCtD
Didanosine—Anaemia—Lisinopril—dilated cardiomyopathy	0.0024	0.00763	CcSEcCtD
Didanosine—Malaise—Lisinopril—dilated cardiomyopathy	0.00234	0.00745	CcSEcCtD
Didanosine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00232	0.00739	CcSEcCtD
Didanosine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00231	0.00735	CcSEcCtD
Didanosine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00223	0.0071	CcSEcCtD
Didanosine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00223	0.0071	CcSEcCtD
Didanosine—Myalgia—Lisinopril—dilated cardiomyopathy	0.00221	0.00703	CcSEcCtD
Didanosine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00221	0.00703	CcSEcCtD
Didanosine—Discomfort—Lisinopril—dilated cardiomyopathy	0.00218	0.00695	CcSEcCtD
Didanosine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00216	0.00688	CcSEcCtD
Didanosine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00212	0.00674	CcSEcCtD
Didanosine—PNP—Nucleotide metabolism—GPX1—dilated cardiomyopathy	0.00211	0.0555	CbGpPWpGaD
Didanosine—Infection—Lisinopril—dilated cardiomyopathy	0.0021	0.0067	CcSEcCtD
Didanosine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00208	0.00662	CcSEcCtD
Didanosine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00207	0.0066	CcSEcCtD
Didanosine—Asthenia—Furosemide—dilated cardiomyopathy	0.00202	0.00644	CcSEcCtD
Didanosine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00202	0.00642	CcSEcCtD
Didanosine—Pruritus—Furosemide—dilated cardiomyopathy	0.002	0.00635	CcSEcCtD
Didanosine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00193	0.00615	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00193	0.00614	CcSEcCtD
Didanosine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.0019	0.00605	CcSEcCtD
Didanosine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00186	0.00593	CcSEcCtD
Didanosine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00184	0.00586	CcSEcCtD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00183	0.0482	CbGpPWpGaD
Didanosine—Pain—Lisinopril—dilated cardiomyopathy	0.00181	0.00576	CcSEcCtD
Didanosine—Vomiting—Furosemide—dilated cardiomyopathy	0.00179	0.00571	CcSEcCtD
Didanosine—Rash—Furosemide—dilated cardiomyopathy	0.00178	0.00566	CcSEcCtD
Didanosine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00178	0.00566	CcSEcCtD
Didanosine—Headache—Furosemide—dilated cardiomyopathy	0.00177	0.00563	CcSEcCtD
Didanosine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00173	0.00551	CcSEcCtD
Didanosine—Nausea—Furosemide—dilated cardiomyopathy	0.00167	0.00534	CcSEcCtD
Didanosine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00167	0.00533	CcSEcCtD
Didanosine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00167	0.00533	CcSEcCtD
Didanosine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00156	0.00497	CcSEcCtD
Didanosine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00152	0.00484	CcSEcCtD
Didanosine—Pruritus—Lisinopril—dilated cardiomyopathy	0.0015	0.00477	CcSEcCtD
Didanosine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00145	0.00461	CcSEcCtD
Didanosine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00135	0.00429	CcSEcCtD
Didanosine—Rash—Lisinopril—dilated cardiomyopathy	0.00133	0.00425	CcSEcCtD
Didanosine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00133	0.00425	CcSEcCtD
Didanosine—Headache—Lisinopril—dilated cardiomyopathy	0.00133	0.00422	CcSEcCtD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00127	0.0334	CbGpPWpGaD
Didanosine—Nausea—Lisinopril—dilated cardiomyopathy	0.00126	0.004	CcSEcCtD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00112	0.0294	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000957	0.0252	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000931	0.0245	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000931	0.0245	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000866	0.0228	CbGpPWpGaD
Didanosine—PNP—Metabolism—ANKRD1—dilated cardiomyopathy	0.00083	0.0218	CbGpPWpGaD
Didanosine—PNP—Metabolism—TAZ—dilated cardiomyopathy	0.000781	0.0205	CbGpPWpGaD
Didanosine—PNP—Metabolism—SDHA—dilated cardiomyopathy	0.000706	0.0186	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000663	0.0174	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000645	0.017	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000645	0.017	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.0006	0.0158	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000508	0.0133	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000265	0.00697	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000258	0.00678	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000258	0.00678	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00024	0.00631	CbGpPWpGaD
Didanosine—PNP—Metabolism—GPX1—dilated cardiomyopathy	0.000192	0.00504	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000189	0.00496	CbGpPWpGaD
Didanosine—PNP—Metabolism—CD36—dilated cardiomyopathy	0.000187	0.00491	CbGpPWpGaD
Didanosine—PNP—Metabolism—AGT—dilated cardiomyopathy	0.000168	0.00442	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000131	0.00344	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.23e-05	0.00138	CbGpPWpGaD
